RxNorm March 2026 Monthly Release
RxNorm March 2026 Monthly Release. New Qualitative Distinction: Weight Management. NLM Tech Bull. 2026 Mar-Apr;(469):b1.
March 02, 2026 [posted]
The RxNorm March 2026 monthly release became available on Monday, March 2, 2026.
New Qualitative Distinction: Weight Management.
We have added a new Qualitative Distinction (Weight Management) to differentiate the anti-diabetic and weight loss versions of liraglutide products. Previously Victoza and Saxenda shared the same SCD: 3 ML liraglutide 6 MG/ML Pen Injector. The new QD applies to Saxenda and its related forms. SCDs and SBDs for other liraglutide products are unchanged.
Examples:
|
RXCUI |
TTY |
STR |
|
1598268 |
SBD |
Weight Management 3 ML liraglutide 6 MG/ML Pen Injector [Saxenda] |
|
2735350 |
SCD |
Weight Management 3 ML liraglutide 6 MG/ML Pen Injector |
|
897126 |
SBD |
3 ML liraglutide 6 MG/ML Pen Injector [Victoza] |
|
897122 |
SCD |
3 ML liraglutide 6 MG/ML Pen Injector |
Learn more about Qualitative Distinctions in RxNorm.